Development of experimental pneumonia by infection with penicillin- insensitive Streptococcus pneumoniae in guinea pigs and their treatment with amoxicillin, cefotaxime, and meropenem

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 12, 1996, Pages 2698-2702

  Ponte, Carmen ^a   Parra, Araceli ^a   Nieto, Eva ^a   Soriano, Francisco ^a  

^a Hospital UniversitarioFundación Jiménez Díaz   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; CEFOTAXIME; MEROPENEM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIUM CULTURE; CONTROLLED STUDY; DRUG EFFICACY; GUINEA PIG; INTRATRACHEAL DRUG ADMINISTRATION; LUNG HOMOGENATE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; SURVIVAL RATE;

EID: 0029804776     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.12.2698     Document Type: Article

References (27)

1. Appelbaum, P. C. 1992. Antimicrobial resistance in Streptococcus pneumoniae: an overview. Clin. Infect. Dis. 15:77-83.
2. Azoulay-Dupuis, E., E. Vallée, B. Vener, J. P. Bédos, J. Bauchet, and J. J. Pocidalo. 1992. In vivo efficacy of a new fluoroquinolone, sparfloxacin, against penicillin-susceptible and -resistant and multiresistant strains of Streptococcus pneumoniae in a mouse model of pneumonia. Antimicrob. Agents Chemother. 36:2698-2703.
3. Briles, D., M. J. Crain, B. M. Gray, C. Forman, and J. Yother. 1992. Strong association between capsular type and virulence for mice among human isolates of Streptococcus pneumoniae. Infect. Immun. 60:111-116.
4. Cox, A. L., J. M. Meewis, and R. Horton. 1989. Penetration into lung tissue after intravenous administration of amoxycillin/clavulanate. J. Antimicrob. Chemother. 24(Suppl. B):87-91.
5. Drusano, G. L. 1988. Role of pharmacokinetics in the outcome of infections. Antimicrob. Agents Chemother. 32:289-297.
6. Fitzgeorge, R. B., S. Lever, and A. Baskerville. 1993. A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease. J. Antimicrob. Chemother. 31(Suppl. E): 171-176.
7. Fukasawa, M., Y. Sumita, E. T. Harabe, T. Tanio, H. Nouda, T. Kohzuki, T. Okuda, H. Matsumura, and M. Sunagawa. 1992. Stability of meropenem and effect of 1β-methyl substitution on its stability in the presence of renal dehydropeptidase I. Antimicrob. Agents Chemother. 36:1577-1579.
8. Gordin, F. M., M. G. Rusnak, and M. A. Sande. 1987. Evaluation of combination chemotherapy in a lightly anesthetized animal model of Pseudomonas pneumonia. Antimicrob. Agents Chemother. 31:388-403.
9. Greenblatt, D. J., and J. Koch-Weser. 1975. Clinical pharmacokinetics. N. Engl. J. Med. 297:702-705.
10. Harrison, M. P., S. R. Moss, A. Featherstone, A. G. Fowkes, A. M. Sanders, and D. E. Case. 1989. The disposition and metabolism of meropenem in laboratory animals and man. J. Antimicrob. Chemolher. 24(Suppl. A):265-277.
11. Karchmer, A. W. 1995. Cephalosporins, p. 247-264. In G. L. Mandell, J. E. Bennett, and R. Dolin (ed.), Principles and practice of infectious diseases, 4th ed. Churchill Livingstone, New York.
12. Kawana, M., C. Kawana, and G. S. Giebink. 1992. Penicillin treatment accelerates middle ear inflammation in experimental otitis media. Infect. Immun. 60:1908-1912.
13. Kelly, H. C., M. Hutchison, and S. J. Haworth. 1995. A comparison of the pharmacokinetics of meropenem after administration by intravenous injection over 5 min and intravenous infusion over 30 min. J. Antimicrob. Chemother. 36(Suppl. A):35-41.
14. Makhoued, I. R., D. Merzbach, C. Lichtig, and M. Berant. 1993. Antibiotic treatment of experimental Pseudomonas aeruginosa pneumonia in guinea pigs: Comparison of aerosol and systemic administration. J. Infect. Dis. 168: 1296-1299.
15. McAllister, C. K., J. M. O'Donoghue, and H. N. Beaty. 1975. Experimental pneumococcal meningitis. II. Characterization and quantitation of the inflammatory process. J. Infect. Dis. 132:355-360.
16. Moine, P., E. Vallée, E. Azoulay-Dupuis, P. Bourget, J. P. Bédos, J. Bauchet, and J. J. Pocidalo. 1994. In vivo efficacy of a broad-spectrum cephalosporin, ceftriaxone, against penicillin-susceptible and -resistant strains of Streptococcus pneumoniae in a mouse pneumonia model. Antimicrob. Agents Chemother. 38:1953-1958.
17. Nava, J. M., F. Bella, J. Garau, J. Lite, M. A. Morera, C. Martí, D. Fontanals, B. Font, V. Pineda, S. Uriz, F. Deulofeu, A. Calderón, P. Durán, M. Grau, and A. Agudo. 1994. Predictive factors for invasive disease due to penicillin-resistant Streptococcus pneumoniae: a population-based study. Clin. Infect. Dis. 19:884-890.
18. Pallarés, R., J. Liñares, M. Vadillo, C. Cabellos, F. Manresa, P. F. Viladrich, R. Martín, and F. Gudiol. 1995. Resistance to penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona, Spain. N. Engl. J. Med. 333:474-480.
19. Pennington, J. E., and M. G. Ehrie. 1978. Pathogenesis of Pseudomonas aeruginosa pneumonia during immunosuppression. J. Infect. Dis. 137:764-774.
20. Sato, K., M. K. Quartey, C. L. Liebeler, and G. S. Giebink. 1995. Timing of penicillin treatment influences the course of Streptococcus pneumoniae-induced middle ear inflammation. Antimicrob. Agents Chemother. 39:1896-1898.
21. Smith, G. M., and K. H. Abbott. 1994. Development of experimental respiratory infections in neutropenic rats with either penicillin-resistant Streptococcus pneumoniae or β-lactamase-producing Haemophilus influenzae. Antimicrob. Agents Chemother. 38:608-610.
22. Swenson, J. M., J. A. Hindler, and L. R. Peterson. 1995. Special tests for detecting antibacterial resistance, p. 1356-1367. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (ed.), Manual of clinical microbiology, 6th ed. American Society for Microbiology, Washington, D.C.
23. Tanio, T., H. Nouda, E. Tada, T. Kohzuki, M. Kato, M. Fukasawa, T. Okuda, and S. Kamidono. 1987. SM-7338, a new carbapenem antibiotic: renal dehydropeptidase-I stability and pharmacokinetics in animals, abstr. 758, p. 224. In Program and abstracts of the 27th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
24. Trnovec, T., Z. Kállay, M. Durisová, S. Bezek, and J. Navarova. 1990. Survival after intramuscular or inhalation administration of gentamicin in neutropenic guinea pigs infected by Klebsiella pneumoniae. J. Antimicrob. Chemother. 25:127-132.
25. Tsai, Y. H., C. A. Ferraro, T. Stolfi, J. W. Russell, and J. M. Clark. 1994. In vivo evaluation of a new carbapenem, abstr. F48, p. 126. In Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.
26. Tuomanen, E., B. Hengstler, R. Rich, M. A. Bray, O. Zak, and A. Tomasz. 1987. Nonsteroidal anti-inflammatory agents in the therapy for experimental pneumococcal meningitis. J. Infect. Dis. 155:985-990.
27. Vogelman, B., S. Gudmundsson, J. Leggett, J. Turnige, S. Ebert, and W. A. Craig. 1988. Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model. J. Infect. Dis. 158:831-847.